[ad_1]
SÃO PAULO – The Ibovespa fell on Wednesday (11) with a correction after six consecutive highs. Another factor of instability are the declarations made by the Minister of Economy, Paulo Guedes, the day before, that Brazil may return to a situation of hyperinflation if it does not manage to remove the debt satisfactorily.
“I am very frustrated with the fact that we have been here for two years and have not yet managed to sell any state companies,” he said, noting that without the sale of public assets the government runs “inefficient” companies while the debt grows “like a ball of money. snow”. ”.
International scholarships abroad continue to have a positive impact on the success of coronavirus vaccine trials developed by pharmaceutical companies Pfizer and BioNTech.
Maintaining the rally that started with the result of a 90% prophylaxis efficiency, oil is on the rise again today. A barrel of Brent, used as a benchmark by Petrobras, is up 2.61% to $ 44.75 and a barrel of WTI is up 2.61% to $ 42.44.
Around here, President Jair Bolsonaro disrupts the environment again after statements about the Chinese coronavac vaccine and about the president-elect of the United States, Joe Biden.
Bolsonaro, one of the few leaders who has not yet congratulated Biden, said that when the diplomacy ends, it is necessary to use “gunpowder”, referring to the threat of the Democrat to impose trade barriers to Brazil if the fire in the Amazon does not cease .
As for the coronavirus, Bolsonaro said that Brazil “cannot be a country of ladybugs” when commenting on the death of 160,000 people from the disease. Yesterday, the president took to social media to say that he was right after the death of a patient from the Chinese coronavac vaccine testing group.
Among the indicators, Brazilian retail sales grew 0.6% in September compared to August, showed the Brazilian Institute of Geography and Statistics (IBGE). The expectation, according to the Bloomberg consensus, was that retail sales would have increased by 1.4% in the monthly comparison after a previous increase of 3.4% and 8.4% in the annual comparison.
At 10:42 am (Brasilia time), the Ibovespa fell 0.84%, to 104,187 points.
Meanwhile, the commercial dollar rose 0.65% to R $ 5,427 in the purchase and R $ 5,428 in the sale. The future dollar maturing in December recorded gains of 0.38%, at R $ 5.44.
In the future interest market, the ID of January 2022 rises five basis points to 3.37%, the ID of January 2023 rises five basis points to 4.92%, the ID of January 2025 advances five basis points at 6.63% and the DI of January 2027 registered a positive variation of four basis points at 7.40%.
Returning to the domestic scenario, in another confusion, about the Coronavac test vaccine, the Federal Supreme Court (STF) requests information on the suspension of tests by the National Health Surveillance Agency (Anvisa) and the commission of the Chamber of Deputies you can vote on requests for clarification.
Policy and vaccines
The news is still marked by politicization around one of the main bets for vaccination in the country.
On Monday, the same day that Pfizer and BioNTech announced the good results with their vaccine, São Paulo Governor João Doria (PSDB) announced that 120,000 doses of Coronavac, the vaccine produced by China’s Sinovac, would arrive at the Institute. Butantan until November 20.
Another 6 million were expected to arrive by December 20. The state should only have the autonomy to produce the product completely autonomously in 2022.
However, for it to apply to the population, Anvisa would still need to approve Coronavac, which undergoes phase 3 clinical trials in the state.
On Monday, Anvisa announced that it had terminated the Coronavac clinical study following the recording of a “serious adverse event.” On Tuesday, several outlets reported that the incident involved the death of a 32-year-old participant who, however, had committed suicide.
São Paulo state health officials criticized Anvisa, saying the case could not be related to the vaccine. It is not yet clear whether the participant was taking a placebo or a vaccine.
The case reawakened fears that the Bolsonaro government is politicizing vaccination in Brazil, to the detriment of technical issues.
Disputes over Coronavac have escalated since October. The Minister of Health, General Eduardo Pazuello, announced that the federal government intended to buy 46 million doses of Coronavac. Soon after, Bolsonaro rejected it.
On Tuesday, Bolsonaro posted on his Twitter account a report on the suspension of the vaccine tests and wrote “this is the vaccine that Doria wanted all Brazilians to take.” The president said the vaccine could never be mandatory. One more that Jair Bolsonaro wins ”.
The general director of Anvisa, Antônio Barra Torres, affirmed that the documents reporting the death, sent by the Butantan Institute, would be “incomplete” and “insufficient”.
“Faced with incomplete information, the technical area has only one decision to make [de suspender a pesquisa]. In developments there are adverse events, such as pain or redness. And there are serious ones, ranging from hospitalization with risk, sequelae and even death, “he said.
The pressure surrounding the case comes from several fronts. The Independent International Council that evaluates vaccine tests around the world recommended that Anvisa authorize the resumption of tests. The agency should review the application.
In addition, Minister Ricardo Lewandowski, of the STF, determined that Anvisa deliver, within 48 hours, explanations on the “criteria used to carry out the studies and experiments related to the aforementioned vaccine, as well as the stage of approval of this and other vaccines. against covid-19 “.
And deputies Orlando Silva (PCdoB-SP), Perpétua Almeida (PCdoB-AC) and Marcelo Ramos (PL-AM), sign a request that asks the Minister of Health, General Eduardo Pazuello, the Director General of Anvisa (Agência Agencia Nacional of Health Surveillance), Antônio Barra Torres, and the director of the Butantan Institute, Dimas Covas, explain in the Chamber of Deputies why the Coronavac tests were suspended.
Corporate radar
Carrefour Brasil announced on Tuesday an adjusted net income of R $ 757 million in the third quarter of 2020, an increase of 73.1% compared to the same period of 2019, with strong sales growth and cost control.
In the period, the operating result measured by the adjusted consolidated Ebitda grew 18.6%, to R $ 1.34 billion, while the margin yielded to 7.7%, compared to 8.2% the previous year, due to exceptional provisions added in the group bank.
BR Distribuidora registered net income of R $ 335 million in the third quarter, 74.9% less than in the same period of the previous year, with sales affected by the pandemic. Compared to the second quarter, there was a recovery.
Infrastructure concessionaire CCR announced on Tuesday that the manufacturer of solar energy equipment Amerisolar has installed itself in the industrial airport, which is located in the vicinity of the Confins (MG) terminal.
Free InfoMoney training shows you how to find investment opportunities hidden in charts and place your first trade. Look it here!
[ad_2]
